BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Marker Therapeutics Reports Year-End 2024 Corporate and Financial Results

  April 1, 2025

   · 

  11 min read
• Press Releases

  Aprea Therapeutics Announces Dosing of Patient with HPV+ Head and Neck Squamous Cell Carcinoma (HNSCC) in Ongoing ACESOT-1051 Trial

  April 1, 2025

   · 

  7 min read
• Press Releases

  Neurocrine Biosciences Presents Real-World Data on Therapeutic Dose Attainment and Dosing Trends of VMAT2 Inhibitors in Patients With Tardive Dyskinesia

  April 1, 2025

   · 

  12 min read
• Press Releases

  Connect Biopharma Reports 2024 Full-Year Financial Results and Provides Business Update

  April 1, 2025

   · 

  10 min read
• Press Releases

  Rancho BioSciences Appoints Marc Ginsky as Chief Executive Officer

  April 1, 2025

   · 

  3 min read
• Press Releases

  bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024

  April 1, 2025

   · 

  11 min read
• Press Releases

  Trethera Treats a Late Stage, Heavily Pretreated Amyotrophic Lateral Sclerosis (ALS) Patient with TRE 515

  April 1, 2025

   · 

  6 min read
• Press Releases

  Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights

  April 1, 2025

   · 

  9 min read
• Press Releases

  Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

  April 1, 2025

   · 

  12 min read
• Press Releases

  Compass Therapeutics to Host Webcast Highlighting Top-Line Clinical Data from the Ongoing Randomized Phase 2/3 Study Evaluating Tovecimig in Patients with Biliary Tract Cancer

  April 1, 2025

   · 

  1 min read